Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics CorpUTHR · filed Dec 10, 2024

Accession no.
0001562180-24-008301
Filed
Dec 10, 2024
Trade date
Dec 9, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 14 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.68M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 9, 2024Common StockMOption exerciseAcquired+4,500$102.11+$459,4954,500Indirect
Dec 9, 2024Common StockMOption exerciseAcquired+3,000$111.00+$333,0003,000Indirect
Dec 9, 2024Common StockSSaleDisposed−926$366.27F3−$339,166.026,359Indirect
Dec 9, 2024Common StockSSaleDisposed−215$364.92F4−$78,457.87,285Indirect
Dec 9, 2024Common StockSSaleDisposed−3,481$367.54F5−$1,279,406.742,878Indirect
Dec 9, 2024Common StockSSaleDisposed−2,700$368.28F6−$994,356178Indirect
Dec 9, 2024Common StockSSaleDisposed−100$370.75−$37,07578Indirect
Dec 9, 2024Common StockSSaleDisposed−78$372.39−$29,046.420Indirect
Dec 9, 2024Common StockMOption exerciseAcquired+2,500$111.00+$277,5002,500Indirect
Dec 9, 2024Common StockSSaleDisposed−100$364.87−$36,4872,400Indirect
Dec 9, 2024Common StockSSaleDisposed−393$366.58F8−$144,065.942,007Indirect
Dec 9, 2024Common StockSSaleDisposed−1,300$367.73F9−$478,049707Indirect
Dec 9, 2024Common StockSSaleDisposed−607$368.47F10−$223,661.29100Indirect
Dec 9, 2024Common StockSSaleDisposed−100$370.75−$37,0750Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 9, 2024Common StockMOption exerciseDisposed−4,500$0.00$00Indirect
Dec 9, 2024Common StockMOption exerciseDisposed−3,000$0.00$04,148Indirect
Dec 9, 2024Common StockMOption exerciseDisposed−2,500$0.00$032,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

This transaction was executed in multiple trades at prices ranging from $365.90 to $366.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $364.87 to $365.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $367.00 to $367.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $368.03 to $368.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $366.07 to $367.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $367.08 to $368.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $368.25 to $368.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)